NRIX NURIX THERAPEUTICS INC
2026Q1 · CUSIP 67080M103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
194
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
101
Δ whales
+8
Inst. holding value
$1.8B
New positions
43
Closed positions
32
Price momentum (1Q)
-0.8%
Put / Call
1/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q2 | Top 6% | +20.6% | -22.1% |
| 2022Q3 | Top 11% | -29.2% | -29.3% |
| 2021Q1 | Top 8% | +14.5% | +31.9% |
Options Sentiment
Put holders
1
QoQ: -1
Call holders
2
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.46
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-58.4%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-05-31 · SEC filings (XBRL)